Drovin®

Drotaverine

Prescribing Details



Description

Drotaverine Hydrochloride is a new potent synthetic antispasmodic drug, which is readily absorbed from the intestine. Like Papaverine, it acts directly on the smooth muscle fibres, exceeding however, the antispasmodic effect of the standard preparations. Drotaverine Hydrochloride is characterized by its rapid onset of actions which has advantage in case of acute painful spastic conditions. In addition to its spasmolytic and vasodilatory actions Drotaverine Hydrochloride elicits a selective blockade of cardiac beta-receptors.


Uses

Gastric, intestinal or pyloric spasm, cholelithiasis and spastic constipation, tenesmus in dysentery, dysmenorrhoea, peri­pheral vascular disorders. Owing to its freedom from cardiotoxic and hypotensive effects Drotaverine Hydrochloride has outstanding value in the treatment of coronary insufficiency and angina pectoris.


Indications
No Data

Dosage and administration

For tablet
Adults: The usual dose for adults is 1 to 2 tablets three times daily.
Children: Children should be given smaller doses according to age and body weight.
1-6 years: 1/4 to 1/2 tablet once or twice daily.
Over 6 years: 1/2 to 1 tablet daily.

For injection
Adults: 2 to 4ml injection one to three times daily, intramuscularly or subcutaneously. In case of acute stone colics 2 to 4ml may be given by slow intravenous injection.
In peptic ulcer it is expedient to combine Drotaverine Hydrochloride with Atropine or Atropine-like compounds.


Use in pregnancy & lactation

There is no known case of teratogenicity in animal studies.


Geriatric use
No Data

Precautions

Caution should be taken for patients suffering from liver and kidney disease.


Side effects
In rare cases, nausea, flushing of face, perspiration, tachycardia, hyperapnoea and vertigo may occur.

Contraindications

Drovin® is contra-indicated in patients with a history of hypersensitivity to Drotaverine Hydrochloride.


Drug interactions

Levodopa (anti-perkinson effect may be decreased).


Overdose
No Data

Preparation

No Data


Pharmaceutical precautions

Store in a cool dry place. Protect from light.


Presentation

Drovin® Tablets: Yellow, oval shaped tablet with break line on one side and other side plain. Each tablet contains Drotaverine Hydrochloride INN 40mg.

Drovin® Injection: A light yellow clear sterile solution. Each 2ml ampoule contains Drotaverine Hydrochloride INN 40mg.


Package quantities

Drovin® Tablets: Cartons of 100 tablets in Alu-PVC blister.

Drovin® Injection: 5 ampoules in a box.